Effects of vascular endothelial growth factor on the lymphocyte-endothelium interactions: Identification of caveolin-1 and nitric oxide as control points of endothelial cell anergy

Journal of Immunology

Volumn 178, Issue 3, 2007, Pages 1505-1511

  Bouzin, Caroline ^a   Brouet, Agnès ^a   De Vriese, Joelle ^a   DeWever, Julie ^a   Feron, Olivier ^a  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; INTERCELLULAR ADHESION MOLECULE 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL WALL; CANCER IMMUNOTHERAPY; CAVEOLA; CELL ADHESION; CELL INTERACTION; CLONAL ANERGY; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 33846482153     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.3.1505     Document Type: Article

References (28)

1. Greten, T. F., and E. M. Jaffee. 1999. Cancer vaccines. J. Clin. Oncol. 17: 1047-1060.
2. Li, Q., and A. E. Chang. 1999. Adoptive T-cell immunotherapy of cancer. Cytokines Cell Mol. Ther. 5: 105-117.
3. Yu, Z., and N. P. Restifo. 2002. Cancer vaccines: progress reveals new complexities. J. Clin. Invest. 110: 289-294.
4. Wu, N. Z., B. Klitzman, R. Dodge, and M. W. Dewhirst. 1992. Diminished leukocyte-endothelium interaction in tumor microvessels. Cancer Res. 52: 4265-4268.
5. Griffioen, A. W., C. A. Damen, G. H. Blijham, and G. Groenewegen. 1996. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. Blood 88: 667-673.
6. Griffioen, A. W., C. A. Damen, S. Martinotti, G. H. Blijham, and G. Groenewegen. 1996. Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors. Cancer Res. 56: 1111-1117.
7. Jain, R. K., G. C. Koenig, M. Dellian, D. Fukumura, L. L. Munn, and R. J. Melder. 1996. Leukocyte-endothelial adhesion and angiogenesis in tumors. Cancer Metastasis Rev. 15: 195-204.
8. + T-lymphocyte. Cancer Res. 54: 4729-4733.
9. Melder, R. J., G. C. Koenig, B. P. Witwer, N. Safabakhsh, L. L. Munn, and R. K. Jain. 1996. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat. Med. 2: 992-997.
10. Liu, D., H. Jia, D. I. Holmes, A. Stannard, and I. Zachary. 2003. Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1. Arterioscler. Thromb. Vasc. Biol. 23: 2002-2007.
11. Carman, C. V., and T. A. Springer. 2004. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J. Cell Biol. 167: 377-388.
12. Millan, J., L. Hewlett, M. Glyn, D. Toomre, P. Clark, and A. J. Ridley. 2006. Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains. Nat. Cell Biol. 8: 113-123.
13. Labrecque, L., I. Royal, D. S. Surprenant, C. Patterson, D. Gingras, and R. Beliveau. 2003. Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. Mol. Biol. Cell 14: 334-347.
14. Sonveaux, P., P. Martinive, J. DeWever, Z. Batova, G. Daneau, M. Pelat, P. Ghisdal, V. Gregoire, C. Dessy, J. L. Balligand, and O. Feron. 2004. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis. Circ. Res. 95: 154-161.
15. Brouet, A., J. DeWever, P. Martinive, X. Havaux, C. Bouzin, P. Sonveaux, and O. Feron. 2005. Antitumor effects of in vivo caveolin gene delivery are associated with the inhibition of the proangiogenic and vasodilatory effects of nitric oxide. FASEB J. 19: 602-604.
16. Amos, C., I. A. Romero, C. Schultze, J. Rousell, J. D. Pearson, J. Greenwood, and P. Adamson. 2001. Cross-linking of brain endothelial intercellular adhesion molecule (ICAM)-1 induces association of ICAM-1 with detergent-insoluble cytoskeletal fraction. Arterioscler. Thromb. Vasc. Biol. 21: 810-816.
17. Tilghman, R. W., and R. L. Hoover. 2002. E-selectin and ICAM-1 are incorporated into detergent-insoluble membrane domains following clustering in endothelial cells. FEBS Lett. 525: 83-87.
18. Yoshida, M., W. F. Westlin, N. Wang, D. E. Ingber, A. Rosenzweig, N. Resnick, and M. A. Gimbrone, Jr. 1996. Leukocyte adhesion to vascular endothelium induces E-selectin linkage to the actin cytoskeleton. J. Cell Biol. 133: 445-455.
19. Sbaa, E., F. Frerart, and O. Feron. 2005. The double regulation of endothelial nitric oxide synthase by caveolae and caveolin: a paradox solved through the study of angiogenesis. Trends Cardiovasc. Med. 15: 157-162.
20. Ahluwalia, A., P. Foster, R. S. Scotland, P. G. McLean, A. Mathur, M. Perretti, S. Moncada, and A. J. Hobbs. 2004. Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment. Proc. Natl. Acad. Sci. USA 101: 1386-1391.
21. Gratton, J. P., M. I. Lin, J. Yu, E. D. Weiss, Z. L. Jiang, T. A. Fairchild, Y. Iwakiri, R. Groszmann, K. P. Claffey, Y. C. Cheng, and W. C. Sessa. 2003. Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. Cancer Cells 4: 31-39.
22. Min, J. K., Y. M. Lee, J. H. Kim, Y. M. Kim, S. W. Kim, S. Y. Lee, Y. S. Gho, G. T. Oh, and Y. G. Kwon. 2005. Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-κB pathway. Circ. Res. 96: 300-307.
23. Detmar, M., L. F. Brown, M. P. Schon, B. M. Elicker, P. Velasco, L. Richard, D. Fukumura, W. Monsky, K. P. Claffey, and R. K. Jain. 1998. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J. Invest. Dermatol. 111: 1-6.
24. Dirkx, A. E., M. G. Oude Egbrink, M. J. Kuijpers, S. T. van der Niet, V. V. Heijnen, J. C. Bouma-ter Steege, J. Wagstaff, and A. W. Griffioen. 2003. Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression. Cancer Res. 63: 2322-2329.
25. Bernot, D., A. M. Benoliel, F. Peiretti, S. Lopez, B. Bonardo, P. Bongrand, I. Juhan-Vague, and G. Nalbone. 2003. Effect of atorvastatin on adhesive phenotype of human endothelial cells activated by tumor necrosis factor α. J. Cardiovasc. Pharmacol. 41: 316-324.
26. Ikeda, S., M. Ushio-Fukai, L. Zuo, T. Tojo, S. Dikalov, N. A. Patrushev, and R. W. Alexander. 2005. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis. Circ. Res. 96: 467-475.
27. Liu, J., B. Razani, S. Tang, B. I. Terman, J. A. Ware, and M. P. Lisanti. 1999. Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells: angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1. J. Biol. Chem. 274: 15781-15785.
28. Regina, A., J. Jodoin, P. Khoueir, Y. Rolland, F. Berthelet, R. Moumdjian, L. Fenart, R. Cecchelli, M. Demeule, and R. Beliveau. 2004. Down-regulation of caveolin-1 in glioma vasculature: modulation by radiotherapy. J. Neurosci. Res. 75: 291-299.